PL1703901T3 - Farmaceutyczna kompozycja zawierająca alkohol 2,4-dichlorobenzylowy i amylometakrezol - Google Patents

Farmaceutyczna kompozycja zawierająca alkohol 2,4-dichlorobenzylowy i amylometakrezol

Info

Publication number
PL1703901T3
PL1703901T3 PL05701832T PL05701832T PL1703901T3 PL 1703901 T3 PL1703901 T3 PL 1703901T3 PL 05701832 T PL05701832 T PL 05701832T PL 05701832 T PL05701832 T PL 05701832T PL 1703901 T3 PL1703901 T3 PL 1703901T3
Authority
PL
Poland
Prior art keywords
amylmetacresol
pharmaceutical composition
dichlorobenzyl alcohol
dichlorobenzyl
alcohol
Prior art date
Application number
PL05701832T
Other languages
English (en)
Inventor
Ian Gibb
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of PL1703901T3 publication Critical patent/PL1703901T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • A61K31/055Phenols the aromatic ring being substituted by halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL05701832T 2004-01-14 2005-01-11 Farmaceutyczna kompozycja zawierająca alkohol 2,4-dichlorobenzylowy i amylometakrezol PL1703901T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0400774.6A GB0400774D0 (en) 2004-01-14 2004-01-14 Pharmaceutical composition
PCT/GB2005/000062 WO2005067906A2 (en) 2004-01-14 2005-01-11 Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol
EP05701832A EP1703901B1 (en) 2004-01-14 2005-01-11 Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol

Publications (1)

Publication Number Publication Date
PL1703901T3 true PL1703901T3 (pl) 2009-04-30

Family

ID=31726167

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05701832T PL1703901T3 (pl) 2004-01-14 2005-01-11 Farmaceutyczna kompozycja zawierająca alkohol 2,4-dichlorobenzylowy i amylometakrezol

Country Status (12)

Country Link
EP (1) EP1703901B1 (pl)
CN (1) CN1909894B (pl)
AT (1) ATE410154T1 (pl)
DE (1) DE602005010203D1 (pl)
ES (1) ES2313281T3 (pl)
GB (1) GB0400774D0 (pl)
MY (1) MY139425A (pl)
PL (1) PL1703901T3 (pl)
PT (1) PT1703901E (pl)
RU (1) RU2366411C2 (pl)
TW (1) TWI349545B (pl)
WO (1) WO2005067906A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005017475A1 (de) * 2005-04-16 2006-10-19 Roland Pilot Werbesoftware für Mediale Plattformen
GB2453770A (en) 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
GB201001048D0 (en) 2010-01-22 2010-03-10 Aesica Pharmaceuticals Ltd Antiseptic gum
GB201013183D0 (en) * 2010-08-05 2010-09-22 Aesica Pharmaceuticals Ltd Efficient and cost-effective process for the manufacture of amyl m-cresol
CN114073685B (zh) * 2020-08-18 2024-12-06 盈科瑞(横琴)药物研究院有限公司 甲酚在治疗冠状病毒感染性疾病药物中的应用
CN114073686B (zh) * 2020-08-18 2024-08-23 盈科瑞(横琴)药物研究院有限公司 间甲酚在治疗冠状病毒感染性疾病药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123528A (en) * 1964-03-03 New therapeutic compositions
GB865672A (en) * 1957-06-27 1961-04-19 Boots Pure Drug Co Ltd Antiseptic therapeutic compositions comprising 2:4-dichlorobenzyl alcohol
GB9507883D0 (en) * 1995-04-18 1995-05-31 Retroscreen Ltd Compounds

Also Published As

Publication number Publication date
PT1703901E (pt) 2008-12-02
TWI349545B (en) 2011-10-01
TW200536520A (en) 2005-11-16
CN1909894B (zh) 2010-05-26
CN1909894A (zh) 2007-02-07
ES2313281T3 (es) 2009-03-01
GB0400774D0 (en) 2004-02-18
ATE410154T1 (de) 2008-10-15
RU2006129278A (ru) 2008-02-20
WO2005067906A2 (en) 2005-07-28
DE602005010203D1 (de) 2008-11-20
EP1703901B1 (en) 2008-10-08
WO2005067906A3 (en) 2006-02-02
RU2366411C2 (ru) 2009-09-10
EP1703901A2 (en) 2006-09-27
MY139425A (en) 2009-09-30

Similar Documents

Publication Publication Date Title
MX2010002318A (es) Derivados azaindol 2,3-sustituidos para tratar infecciones virales.
TW200833662A (en) 4,5-ring annulated indole derivatives and methods of use thereof
TW200728285A (en) Diacylindazole derivatives as inhibitors of lipases and phospholipases
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
CY1112560T1 (el) Πνευμονικη μεταφορα των αμινογλυκοσιδων
IL192103A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
WO2005018535A3 (en) Compositions and methods for treatment of severe acute respiratory syndrome (sars)
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
ECSP078057A (es) Formulaciones de estrógenos conjugados y bazedoxifeno
TN2011000204A1 (en) Cycloundecadepsipeptide compounds and use of said compounds as a medicament
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
PT1703901E (pt) Composição farmacêutica
ATE399558T1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
BR0111785A (pt) Composições e métodos para tratamento de candidìase
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
DE60041198D1 (de) Antimikrobielle zusammensetzungen
NO20065791L (no) Asyklovir-formuleringer
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.
JO2666B1 (en) Use of agomelatine for medications to treat bilateral mental disorders
MX2007013449A (es) Composicion cosmetica para despigmentacion o aclaracion que comprende al menos una oxazolina como un ingrediente activo.
TW200616651A (en) Mussel extract composition with enhanced anti-inflammatory activity
MX2007004040A (es) Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.
WO2006091222A3 (en) Methods of treating and preventing severe acute respiratory syndrome (sars) with avr118
MXPA04006269A (es) Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.
UA89044C2 (en) Medicinal agent